tryptophan has been researched along with trichostatin a in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
Buzanska, L; Pastwinska, A; Pienkowska-Grela, B; Podobinska, M; Sypecka, J; Szablowska-Gadomska, I; Zayat, V | 1 |
Dikmen, M; Kaya-Tilki, E | 1 |
3 other study(ies) available for tryptophan and trichostatin a
Article | Year |
---|---|
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood.
Topics: Cell Differentiation; Cells, Cultured; Cellular Reprogramming; DNA Methylation; Enzyme Inhibitors; Fetal Blood; Gene Expression Regulation; Germ Layers; Humans; Hydroxamic Acids; Indoles; Induced Pluripotent Stem Cells; Karyotyping; Oxygen; Phthalimides; Pluripotent Stem Cells; Propionates; Time Factors; Transcription Factors; Transfection; Tryptophan | 2012 |
Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Carbamates; Chlamydophila Infections; Chlamydophila pneumoniae; Epigenesis, Genetic; Humans; Hydroxamic Acids; Inflammation; Neuroprotective Agents; Peptide Fragments; Phthalimides; THP-1 Cells; Tryptophan | 2021 |